SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.170+1.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: donpat who wrote (9876)2/22/2018 9:59:29 AM
From: donpat  Read Replies (1) of 12873
 
She is a member of Mid Atlantic Bio Angels, a member of AAAS and a board member at the Centre for Molecular Medicine and Therapeutics at the University of British Columbia.
MABA

Who We Are

Mid Atlantic Bio Angels Group
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels.

MABA places no geographical restrictions or requirements for presenting companies, as long as meaningful and effective post-investment monitoring of these companies can be achieved.

MABA angels meet monthly (except in the summer) in the New York City area, to hear presentations from companies spanning the entire spectrum of life sciences.

Our group follows a multi-step pre-screening process, prior to inviting companies to present to our group. Please visit the "Entrepreneurs" tab to read our investment criteria and to submit an application to our group.
If you are an active life science angel investor, and wish to join our group, please visit our Members page.

Endeavours
MABA maintains an active dialogue with and seeks to invest and share due diligence with other angels and angel groups.
In June of 2016 MABA formed a closed-end investment pool (Pool) funded solely by current, active MABA members. The Pool is intended to enable these members to diversify their portfolios by collectively making more frequent, and smaller investments in a greater number of companies (Pool press release).
MABA also organizes a series of events called 1st Pitch Life Science to encourage and educate aspiring life science entrepreneurs who know they may be too early to seek investment but want the opportunity to practice their pitch and to receive constructive criticism from experienced and knowledgeable professionals.

* * * * *
JOIN US

bioangels.net
Molecular Medicine and Therapeutics at the University of British Columbia.
revolvy.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News